BRAINSWAY LTD. (BWAY)
FORM 6-KBrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
FORM 6-KBrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
📈 **POSITIVE** • Low confidence analysis (45%) • Strong positive catalyst • High growth potential **Sentiment:** Positive (77%) **Content type:** General